APA
Zandberg D. P., Algazi A. P., Jimeno A., Good J. S., Fayette J., Bouganim N., Ready N. E., Clement P. M., Even C., Jang R. W., Wong S., Keilholz U., Gilbert J., Fenton M., Braña I., Henry S., Remenar E., Papai Z., Siu L. L., Jarkowski A., Armstrong J. M., Asubonteng K., Fan J., Melillo G. & Mesía R. (20200504). Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. : European journal of cancer (Oxford, England : 1990).
Chicago
Zandberg Dan P, Algazi Alain P, Jimeno Antonio, Good James S, Fayette Jérôme, Bouganim Nathaniel, Ready Neal E, Clement Paul M, Even Caroline, Jang Raymond W, Wong Stuart, Keilholz Ulrich, Gilbert Jill, Fenton Moon, Braña Irene, Henry Stephanie, Remenar Eva, Papai Zsuzsanna, Siu Lillian L, Jarkowski Anthony, Armstrong Jon M, Asubonteng Kobby, Fan Jean, Melillo Giovanni and Mesía Ricard. 20200504. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. : European journal of cancer (Oxford, England : 1990).
Harvard
Zandberg D. P., Algazi A. P., Jimeno A., Good J. S., Fayette J., Bouganim N., Ready N. E., Clement P. M., Even C., Jang R. W., Wong S., Keilholz U., Gilbert J., Fenton M., Braña I., Henry S., Remenar E., Papai Z., Siu L. L., Jarkowski A., Armstrong J. M., Asubonteng K., Fan J., Melillo G. and Mesía R. (20200504). Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. : European journal of cancer (Oxford, England : 1990).
MLA
Zandberg Dan P, Algazi Alain P, Jimeno Antonio, Good James S, Fayette Jérôme, Bouganim Nathaniel, Ready Neal E, Clement Paul M, Even Caroline, Jang Raymond W, Wong Stuart, Keilholz Ulrich, Gilbert Jill, Fenton Moon, Braña Irene, Henry Stephanie, Remenar Eva, Papai Zsuzsanna, Siu Lillian L, Jarkowski Anthony, Armstrong Jon M, Asubonteng Kobby, Fan Jean, Melillo Giovanni and Mesía Ricard. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. : European journal of cancer (Oxford, England : 1990). 20200504.